Boehringer Ingelheim India appoints Meenal Gauri as Managing Director
Meenal brings in more than 16 years of international experience across Europe, Asia and the Middle East
Meenal brings in more than 16 years of international experience across Europe, Asia and the Middle East
In 2025, over 1 million patients accessed Lilly treatments through LillyDirect
The study will test the company’s lead product, ZI-MA4-1, in patients with advanced solid cancers
The MoU lays the groundwork for deep academic and research collaboration in pharmaceutical technologies
The program offers selected participants advanced access to Promise Bio’s broad-epiproteomic platform
Investment marks continued progress against AbbVie's $100 billion commitment to U.S. R&D and capital investments, including manufacturing, over the next decade
Prostate cancer is one of the fastest-growing cancers in India, with approximately 37,948 new cases each year
The product will target Type 2 diabetes management aligning with unmet needs in India’s expanding metabolic care landscape
If approved, DTX401 would be the first treatment to address the disease at its root cause
The study is a collaboration between AIM, AstraZeneca, and Erasmus Medical Center in the Netherlands
Subscribe To Our Newsletter & Stay Updated